# RELISTOR
> **NDA208271** · New Drug Application · Sponsor: SALIX · Approved 2016-07-19
## Drug
- **FDA Application Number:** NDA208271
- **Application type:** New Drug Application
- **Brand name:** RELISTOR
- **Generic name:** METHYLNALTREXONE BROMIDE
- **Active ingredients:** METHYLNALTREXONE BROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX
- **Manufacturer:** Salix Pharmaceuticals, Inc.
- **First approval:** 2016-07-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208271)
---
*AI Analytics · CC0 1.0*